Revenue continues to be impacted by lower business from a single large molecule biologics client. Excluding this, the underlying business showed steady momentum.

Dipan Mehta, Director at Elixir Equities, stays constructive on Bajaj Finance, citing diversification and stable credit costs. He favours platform-led food businesses over traditional QSR…

HEG reported a net loss of ₹119 crore compared to a loss of ₹69 crore in the fourth quarter of the previous year. Its other…

This is the first instance in nearly two years that the company will be considering a buyback of equity shares. The last instance of Bajaj…

Qualcomm shares jump 15% as CEO Cristiano Amon signals smartphone rebound and data center growth, despite Q3 revenue and profit forecasts missing analyst estimates

The rupee opened at 95.02 per US dollar, compared with Wednesday’s  (April 29’s) close of 94.85.

Motilal Oswal Financial Services reported an MTM loss of ₹716 crore in Q4, compared to a gain of ₹197 crore in Q3, leading to a…

The inspection was conducted between April 20 and April 29, 2026 and covered three Biologics manufacturing units, five quality testing laboratories and two warehouses.

HUL’s volume growth is expected to be in low-single-digits from the same quarter last year. The number in the previous quarter was also 4%.

Gold and silver rebound as a softer US dollar lifts COMEX prices, while high Brent crude, inflation worries and Fed policy keep bullion outlook uncertain.